Sandra E. Nicholson
13Patents
3h-index
25Co-inventors
60Inventor score
Filing activity: Jan 21, 1997 → Apr 13, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10975149B2 | Inhibition of cytokine-induced SH2 protein in NK cells | Emerging Cross-Sectional Technologies | 8 | Active |
| US6323317A | Therapeutic and diagnostics proteins comprising a SOCS box | Chemistry; Metallurgy | 6 | Expired |
| US5902584A | Antibodies which bind the G-CSF receptor extracelluar domain and methods of treatment | Human Necessities | 4 | Expired |
| US11104735B2 | Inhibition of cytokine-induced SH2 protein in NK cells | Emerging Cross-Sectional Technologies | 3 | Active |
| US7256007B2 | Methods of regulating cytokine signalling | Human Necessities | 1 | Expired |
| US6905842B1 | Therapeutic and diagnostic agents | Human Necessities | 1 | Expired |
| US7049418B2 | Therapeutic and diagnostic agents comprising a SOCS box | Chemistry; Metallurgy | 1 | Expired |
| US11279760B2 | Inhibition of cytokine-induced SH2 protein in NK cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US11492404B2 | Inhibition of cytokine-induced SH2 protein in NK cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US7279557B2 | Therapeutic and diagnostic agents | Human Necessities | 0 | Expired |
| US7078174B1 | Screening methods using SOCS box-containing peptides | Human Necessities | 0 | Expired |
| US11339220B2 | Inhibition of cytokine-induced SH2 protein in NK cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US7517959B2 | SOCS3 proteins | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.